Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biopsy and blood-based molecular biomarker of inflammation in IBD
Carmen Argmann, Ruixue Hou, Ryan C. Ungaro, et al.
Gut (2022) Vol. 72, Iss. 7, pp. 1271-1287
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

A disease-associated gene desert directs macrophage inflammation through ETS2
Christina T. Stankey, Christophe Bourges, Lea-Maxie Haag, et al.
Nature (2024) Vol. 630, Iss. 8016, pp. 447-456
Open Access | Times Cited: 28
Navigating the complexities of drug development for inflammatory bowel disease
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 18
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis
Pablo Canales-Herrerías, Mathieu Uzzan, Akihiro Seki, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Open Access | Times Cited: 12
Deciphering sepsis: transforming diagnosis and treatment through systems immunology
Robert E. W. Hancock, Andy An, Claúdia C. dos Santos, et al.
Frontiers in Science (2025) Vol. 2
Open Access | Times Cited: 1
Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis
Peilin Guo, Wenjing Wang, Qian Xiang, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 9, pp. 1502-1518.e9
Closed Access | Times Cited: 10
Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease
Wei Chen, Daosheng Wang, Xing Deng, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Challenges in IBD Research 2024: Precision Medicine
Sana Syed, Brigid S. Boland, Lauren T Bourke, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S39-S54
Open Access | Times Cited: 6
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 9, pp. 1266-1279
Open Access | Times Cited: 6
A Simple Endoscopic Score for Crohn's Disease (SES‐CD) ≥ 7 Predicts Disease Progression
Jellyana Peraza, Marco Emilio Kaper, A Bargas, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Joint analysis of genome‐wide cross‐trait and multi‐omics reveals molecular mechanisms of inflammatory bowel disease and nominates its novel therapeutic genes
Zhu Zi-jun, Rongxing Wei, Hailong Li, et al.
The FASEB Journal (2025) Vol. 39, Iss. 1
Closed Access
Interactions between NAD+ metabolism and immune cell infiltration in ulcerative colitis: subtype identification and development of novel diagnostic models
Linglin Tian, Huiyang Gao, Yao Tian, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Multimodal single-cell analyses reveal mechanisms of perianal fistula in diverse patients with Crohn’s disease
Rachel Levantovsky, Christopher Tastad, Jiayu Zhang, et al.
Med (2024) Vol. 5, Iss. 8, pp. 886-908.e11
Closed Access | Times Cited: 4
Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach
Edia Stemmer, Tamar Zahavi, Maoz Kellerman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Comprehensive overview of novel chemical drugs for ulcerative colitis: focusing on phase 3 and beyond
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 485-499
Closed Access | Times Cited: 3
Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean
Philipp Rausch, Sarah Ellul, Anthea Pisani, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 7, pp. 1118-1132
Open Access | Times Cited: 8
Comprehensive Analysis of PANoptosis-Related Gene Signature of Ulcerative Colitis
Jun‐Meng Wang, Yang Jiao, Wan-Yu Xia, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 348-348
Open Access | Times Cited: 8
Construction of a molecular inflammatory predictive model with histone modification-related genes and identification of CAMK2D as a potential response signature to infliximab in ulcerative colitis
Shuyu Ye, Yongqing Lyu, Libin Chen, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 2
To die or not to die: Gasdermins in intestinal health and disease
Zhaoyu Lin, Qianyue Chen, Hai‐Bin Ruan
Seminars in Immunology (2024) Vol. 71, pp. 101865-101865
Closed Access | Times Cited: 2
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
Tom Thomas, Matthias Friedrich, Charlotte Rich-Griffin, et al.
Nature Immunology (2024) Vol. 25, Iss. 11, pp. 2152-2165
Open Access | Times Cited: 2
Bacterial clade-specific analysis identifies distinct epithelial responses in inflammatory bowel disease
Gemma L. D’Adamo, Michelle Chonwerawong, Linden J. Gearing, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 7, pp. 101124-101124
Open Access | Times Cited: 6
Defining Biological Remission in Crohn’s Disease: Interest, Challenges and Future Directions
Nicolas Pierre, Sophie Vieujean, Laurent Peyrin‐Biroulet, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 10, pp. 1698-1702
Open Access | Times Cited: 5
Elucidating the role of TWIST1 in ulcerative colitis: a comprehensive bioinformatics and machine learning approach
Wenjie Ou, Zhaoxue Qi, Ning Liu, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis
Michail Spathakis, Nikolas Dovrolis, Eirini Filidou, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 492-492
Open Access | Times Cited: 1
Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis
Marisol Alvarez-Martinez, Luke S. Cox, Claire Pearson, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 886-901
Open Access | Times Cited: 1
Stromal-like Cells Are Found in Peripheral Blood of Inflammatory Bowel Disease Patients and Correlate with Immune Activation State
Amanda M. Honan, Gillian E. Jacobsen, Hannah Drum, et al.
Clinical and Translational Gastroenterology (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top